Statistics found here the category is Health and social responses (HSR)

Category	Title
HSR	HSR-1. Opioid substitution treatment clients as a percentage of the estimated number of problem opioid users, 2008 or most recent year available
HSR	HSR-1. Year of introduction of methadone maintenance treatment (MMT), high-dosage buprenorphine treatment (HDBT), buprenorphine/naloxone combination, heroin-assisted treatment and slow-release morphine
HSR	HSR-2. Estimated number of clients in opioid substitution treatment (OST) in EU 15–12, 1993–2008
HSR	HSR-2. Legal framework of opioid substitution treatment initiation, continuation and dispensing (by substitution medication) in EU-27, Croatia, Turkey and Norway in 2008 Part (i) Legal framework regarding the initiation of OST by substitution medication
HSR	HSR-2. Legal framework of opioid substitution treatment initiation, continuation and dispensing (by substitution medication) in EU-27, Croatia, Turkey and Norway in 2008 Part (ii) Legal framework regarding the continuation of OST by substitution medication
HSR	HSR-2. Legal framework of opioid substitution treatment initiation, continuation and dispensing (by substitution medication) in EU-27, Croatia, Turkey and Norway in 2008 Part (iii) Legal framework regarding the dispensing of substitution medications
HSR	HSR-3. Syringes distributed through specialised programmes per estimated IDU in 2008 or more recent year
HSR	HSR-3. Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST) Part (i): Estimates of clients in methadone treatment or opioid substitution in EU-27, Croatia, Turkey and Norway, 1993–2008
HSR	HSR-3. Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST) Part (ii) Estimates and share of clients in methadone (MMT) and high-dosage buprenorphine (HDBT) treatment in EU-27, Croatia, Turkey and Norway in 2008
HSR	HSR-3. Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST) Part (iii) Methodological notes EU-27, Croatia, Turkey and Norway, 2003–2008
HSR	HSR-4. Proportion of prison population receiving opioid substitution treatment (OST), 2008
HSR	HSR-4. Year of introduction of needle and syringe programmes (NSPs) and types of programmes available in 2008
HSR	HSR-5. Syringes provided through needle and syringe programmes (NSPs), 2003, 2005, 2007 and 2008
HSR	HSR-6. Hepatitis B immunization in EU 27, Croatia, Turkey and Norway
HSR	HSR-7. Health responses in prison Part (i) Level of provision of selected health responses to prisoners in 26 EU countries, Norway and Turkey in 2008 (expert ratings)
HSR	HSR-7. Health responses in prison Part (ii) Availability of specific responses to prisoners in 26 EU countries, Norway and Turkey in 2008 (expert ratings)
HSR	HSR-8. Responses to drug related deaths in Europe Part (i) Provision of selected responses to reduce drug related deaths in 26 EU countries, Norway and Turkey in 2008 (expert ratings)
HSR	HSR-8. Responses to drug related deaths in Europe Part (ii). Availability of information material on drug-related deaths and emergencies for specific target groups in 26 EU countries, Norway and Turkey in 2008
HSR	HSR-9. Opioid substitution treatment in prison in EU 27, Croatia, Turkey and Norway